Viscus Biologics
PrivateLast Round
Grant
Oct 20, 2014
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Viscus Biologics operates in Healthcare & Life Sciences and is based in Cleveland, Ohio. Its latest recorded funding round was a Grant round in October 2014.
Viscus Biologics is a biotechnology company that specializes in the development and manufacturing of extracellular matrix (ECM) biomaterials and medical devices for regenerative medicine.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Advanced Materials
Business Model
B2B
Customer Profile
Services & Consulting, Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Viscus Biologics Comparables
Compare Viscus Biologics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Integer Holdings Corporation | 78% | |
| Novex Innovations | 77% | |
| Stemmatters | 76% |
For institutional investors. Book with your work email.
Viscus Biologics Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Viscus Biologics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Ohio Third Frontier Commission | Grant |
| Global Cardiovascular Innovation Center | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 14, 2026
Open roles increased to 7, 2.3x the trailing average.
- May 11, 2026
Monthly visitors increased 73% MoM.
For institutional investors. Book with your work email.
Viscus Biologics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Viscus Biologics's valuation, stock price, and market status.
Is Viscus Biologics a public or private company?
Viscus Biologics is a private company.
What is the current stock price of Viscus Biologics?
Viscus Biologics is a private company, so its shares have no public market price. Caplight tracks Viscus Biologics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Viscus Biologics worth (valuation)?
Valuation information for Viscus Biologics is not publicly available.
Can I buy Viscus Biologics stock?
Viscus Biologics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Viscus Biologics's last funding round?
Viscus Biologics's most recent funding round was Grant on October 20, 2014.
Who are the main investors in Viscus Biologics?
Key investors in Viscus Biologics include Ohio Third Frontier Commission, Global Cardiovascular Innovation Center.
Will Viscus Biologics IPO soon?
No public IPO plans have been announced for Viscus Biologics.
How can I track Viscus Biologics secondary market activity?
Caplight tracks bids, offers, and trades in Viscus Biologics's shares on secondary markets.